Immune Response Clinical Trial
Official title:
Investigating the Time of Nelfinavir Treatment Necessary for an Increase in Thymic Naive T Cells in Adults.
Our group has shown that HAART increases the thymic production of naïve T cells in the healthy adult, thereby boosting the immune system. We propose to investigate the amount of and length of Nelfinavir therapy necessary to increase those cells in adults. Subjects will be treated with Nelfinavir, and blood will be sampled at variable times to determine the immune response in peripheral blood.
Blood will be collected at several time points during the study. DNA will be isolated from
peripheral blood lymphocytes (PBL) and assessed for signal point (sj) TREC content relative
to genomic CCR5 copies by real time PCR in a spectoflourometic thermal cycler. TREC values
will be expressed as TREC copy number per copies of CCR5 or TREC/PBLs.
We anticipate that we will confirm our previous observations that nelfinavir therapy will
increase TRECs, indicating naive T cell production from the thymus. The proposed study will
determine the time course of the anticipated increase in TREC/PBLs.
;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05515263 -
Snack Foods and Their Impact on the Immune Response Following Influenza Vaccination
|
N/A | |
Completed |
NCT02872311 -
Open-Label Influenza Vaccine Evaluation
|
N/A | |
Completed |
NCT01861613 -
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
|
Phase 4 | |
Completed |
NCT03982069 -
Immunologic Response to FluMist vs. Flucelvax
|
Phase 4 | |
Recruiting |
NCT06041867 -
Agaricus Bisporus and Influenza Vaccination Response
|
N/A | |
Completed |
NCT03614975 -
Immunologic Response to Influenza Vaccination in Children and Adolescents
|
Phase 4 | |
Completed |
NCT04573543 -
The Role of Immune Semaphorins in NAFLD
|
||
Recruiting |
NCT03875703 -
Post-Vaccination Biological Collection
|
||
Completed |
NCT00902278 -
Immune Responses Induced by Different Licensed Influenza Vaccines
|
N/A | |
Recruiting |
NCT04274348 -
Staphylococcal Toxins in Atopic Dermatitis and Eczema Herpeticum
|
N/A | |
Active, not recruiting |
NCT05534893 -
Effect of Blueberries on Immunity and Response to Flu Vaccination
|
N/A | |
Completed |
NCT05970887 -
Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines
|
Phase 4 | |
Completed |
NCT05706350 -
Plant Stanol Esters and Influenza Vaccination
|
N/A | |
Completed |
NCT03167593 -
Effects of Lactobacillus Coryniformis CECT5711 on Immune Response to Influenza Vaccination in Adults Over 65.
|
Phase 2 | |
Completed |
NCT04386408 -
Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections
|
Phase 1 | |
Completed |
NCT02933931 -
Immune Durability After VSV-EBOV Vaccination
|
||
Recruiting |
NCT01289535 -
Immune Response Analysis to Influenza Vaccine in Elderly Aged Over 65 Years
|
Phase 4 | |
Active, not recruiting |
NCT02441426 -
Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development
|
N/A | |
Recruiting |
NCT03399357 -
Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC Trial
|
N/A | |
Recruiting |
NCT06404749 -
Fungal Fiber for Gut Health
|
N/A |